Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio

被引:11
|
作者
Noguchi, Yoshihiro [1 ]
Aoyama, Keisuke [1 ]
Kubo, Satoaki [1 ]
Tachi, Tomoya [1 ]
Teramachi, Hitomi [1 ,2 ]
机构
[1] Gifu Pharmaceut Univ, Lab Clin Pharm, 1-25-4 Daigakunishi, Gifu, Gifu 5011196, Japan
[2] Gifu Pharmaceut Univ, Lab Community Hlth Pharm, Gifu, Gifu 5011196, Japan
关键词
spontaneous reporting systems; drug-drug interaction; proportional reporting ratio; combination risk ratio; concomitant signal score;
D O I
10.3390/ph14010004
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
There is a current demand for "safety signal" screening, not only for single drugs but also for drug-drug interactions. The detection of drug-drug interaction signals using the proportional reporting ratio (PRR) has been reported, such as through using the combination risk ratio (CRR). However, the CRR does not consider the overlap between the lower limit of the 95% confidence interval of the PRR of concomitant-use drugs and the upper limit of the 95% confidence interval of the PRR of single drugs. In this study, we proposed the concomitant signal score (CSS), with the improved detection criteria, to overcome the issues associated with the CRR. "Hypothetical" true data were generated through a combination of signals detected using three detection algorithms. The signal detection accuracy of the analytical model under investigation was verified using machine learning indicators. The CSS presented improved signal detection when the number of reports was >= 3, with respect to the following metrics: accuracy (CRR: 0.752 -> CSS: 0.817), Youden's index (CRR: 0.555 -> CSS: 0.661), and F-measure (CRR: 0.780 -> CSS: 0.820). The proposed model significantly improved the accuracy of signal detection for drug-drug interactions using the PRR.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [41] Evaluation of Drug-Drug Interaction Potential Between Sacubitril/Valsartan (LCZ696) and Statins Using a Physiologically Based Pharmacokinetic Model
    Lin, Wen
    Ji, Tao
    Einolf, Heidi
    Ayalasomayajula, Surya
    Lin, Tsu-Han
    Hanna, Imad
    Heimbach, Tycho
    Breen, Christopher
    Jarugula, Venkateswar
    He, Handan
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (05) : 1439 - 1451
  • [42] Assessment of OATP transporter-mediated drug-drug interaction using physiologically-based pharmacokinetic (PBPK) modeling - a case example
    Chen, Yuan
    Zhu, Rui
    Ma, Fang
    Mao, Jialin
    Chen, Eugene C.
    Choo, Edna F.
    Sahasranaman, Srikumar
    Liu, Lichuan
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2018, 39 (09) : 420 - 430
  • [43] Risk Evaluation for Acute Kidney Injury Induced by the Concomitant Use of Valacyclovir, Analgesics, and Renin-Angiotensin System Inhibitors: The Detection of Signals of Drug-Drug Interactions
    Inaba, Ichiro
    Kondo, Yuki
    Iwasaki, Shinya
    Tsuruhashi, Satoko
    Akaishi, Ayano
    Morita, Kazuya
    Oniki, Kentaro
    Saruwatari, Junji
    Ishitsuka, Yoichi
    Irie, Tetsumi
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [44] Species differences in the drug-drug interaction between atorvastatin and cyclosporine: In vivo study using a stable isotope-IV method in rats and dogs
    Minami, Keiko
    Higashino, Haruki
    Kataoka, Makoto
    Yamashita, Shinji
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 152
  • [45] A Rapid Study of Botanical Drug-Drug Interaction with Protein by Re-ligand Fishing using Human Serum Albumin-Functionalized Magnetic Nanoparticles
    Qing, Lin-Sen
    Xue, Ying
    Ding, Li-Sheng
    Liu, Yi-Ming
    Liang, Jian
    Liao, Xun
    NATURAL PRODUCT COMMUNICATIONS, 2015, 10 (12) : 2161 - 2163
  • [46] Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use
    Takeshi Honma
    Kenji Onda
    Koichi Masuyama
    BMC Pharmacology and Toxicology, 25
  • [47] Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use
    Honma, Takeshi
    Onda, Kenji
    Masuyama, Koichi
    BMC PHARMACOLOGY & TOXICOLOGY, 2024, 25 (01)
  • [48] Simultaneous Determination of Losartan and Rosuvastatin in Rat Plasma Using Liquid Chromatography-Tandem Mass Spectrometric Technique for Application into Pharmacokinetic and Drug-Drug Interaction Studies
    Wadie, Magdy Atef
    Kishk, Safaa M.
    Darwish, Khaled M.
    Mostafa, Samia M.
    Elgawish, Mohamed Saleh
    CHROMATOGRAPHIA, 2020, 83 (12) : 1477 - 1494
  • [49] Prediction of the Impact of CYP2C19 Polymorphism on Drug-Drug Interaction between Voriconazole and Tacrolimus Using Physiologically- Based Pharmacokinetic Modelling
    Jin, Zhi-Ping
    Yan, Miao
    Li, Si-Ze
    Wang, Bao-Qing
    Xu, Qing
    Wu, Wei
    Li, Xiao-Yu
    Lv, Qian-Zhou
    Xiang, Xiao-Qiang
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 59
  • [50] Application of unbound liver-to-plasma concentration ratio to quantitative projection of cytochrome P450-mediated drug-drug interactions using physiologically based pharmacokinetic modelling approach
    Iwasaki, Shinji
    Kosugi, Yohei
    Zhu, Andy Z. X.
    Nakagawa, Sayaka
    Sano, Noriyasu
    Funami, Miyuki
    Kosaka, Mai
    Furuta, Atsutoshi
    Hirabayashi, Hideki
    Amano, Nobuyuki
    XENOBIOTICA, 2019, 49 (11) : 1251 - 1259